Example: bankruptcy

第十七改正日本薬局方正誤表 - mhlw.go.jp

1 28 6 7 / 11 7 / 1 142 1 349 4 140 200 C 4 14 200 C / 2360 16 NBD NBD 2394 14 BALL 1 BALL 1 2459 3 26 21 20 2 2 / L 2508 29 L L 20 M 2521 22 20 M 20M SYBR Green PCR 2 2529 27 SYBR Green PCR 2 SYBRG reen PCR2 32D clone3 2531 4 32D clone3 32 Dclone3 2549 18 PCR 2 SYBR Green 2558 19 PCR 2 SYBR Green PCR2 SYBRG reen B6 2560 24 B6 Primer F 2562 31 32 33 34 Primer F Primer F Primer

5 体部分ブチルエステル2 対3 縮合物 9.41 試薬・試液 ペオノール,定量用 307、右 ↑20 デジタル分解能:0.25Hz 以下 デジタル分解能:0.25 以下

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of 第十七改正日本薬局方正誤表 - mhlw.go.jp

1 1 28 6 7 / 11 7 / 1 142 1 349 4 140 200 C 4 14 200 C / 2360 16 NBD NBD 2394 14 BALL 1 BALL 1 2459 3 26 21 20 2 2 / L 2508 29 L L 20 M 2521 22 20 M 20M SYBR Green PCR 2 2529 27 SYBR Green PCR 2 SYBRG reen PCR2 32D clone3 2531 4 32D clone3 32 Dclone3 2549 18 PCR 2 SYBR Green 2558 19 PCR 2 SYBR Green PCR2 SYBRG reen B6 2560 24 B6 Primer F 2562 31 32 33 34 Primer F Primer F Primer R Primer R PrimerF PrimerF PrimerR PrimerR 20 M 2567 31 20 M 20M D 2569 17 D D dl 2570 2 dl 10 dl B2 2573 7 B2 B2 2573 4 B2

2 3 2 29 11 17 / (3) 19 (24) 8 / 70 1 4 140 1 2 1 184 3 n20D n2020 187 8 Artemisia argyi H. L veill et Vaniot (Compositae) Artemisia argyi H. L veill et Vaniot 187 3 1/10 1/10 (E) 219 23 221 20 223 24 Achyranthes fauriei H.

3 L veill et Vaniot Achyranthes fauriei Leveill et Vaniot 224 5 260 C( ) 260 C( ) b2 225 17 280 22 5 2 3 307 20 318 9 319 18 338 26 340 9 343 8 ( m 300 400 m2/g) ( m 300 400 m2/g)

4 / 569 17 (8 pt) ( pt) 596 20 (8R)-N-[(1S)-2-Hydroxy-1-methylethyl]-6- methyl-9,10-didehydroergoline-8-carboxam ide monomaleate (8S)-N-[(1S)-2-Hydroxy-1-methylethyl]-6- methyl-9,10-didehydroergoline-8-carboxam ide monomaleate 600 25 6 606 6 855 7 6 ,9-Difluoro-11 ,17,21-trihydroxy-16 -methylpregna-1,4-diene- 3,20-dione 17,21-diacetate 6 ,9-Difluoro-11 ,17,21-trihydroxy-16 -methylpregna-1,4-diene- 3,20-dione 17,21-diaceate 996 15 n20D n2020 1040 1 d2020 d20D 1309 3 (100) ( ) (100) ( )

5 1582 6 (8R)-N-[(1S)-1-(Hydroxymethyl)propyl]-6- methyl-9,10-didehydroergoline-8-carboxam ide monomaleate (8S)-N-[(1S)-1-(Hydroxymethyl)propyl]-6- methyl-9,10-didehydroergoline-8-carboxam ide monomaleate 1652 5 Lansoprazole Delayed-release Orally Disintegrating Tablets Lansoprazole Delayed-release Orally Disintegration Tablets 1671 14 1- -D-Ribofuranosyl-1H-1,2,4-triazole-3-car boxamide 1- -D-Ribofuranosyl-1H-1,2,4,-triazole-3-ca rboxamide 7 / 1793 5 Achyranthes fauriei H.

6 L veill et Vaniot Achyranthes fauriei Leveill et Vaniot 1818 12 10 L 1818 10 10 L 1886 7 4 4 1912 5 / 2423 4 Zygosaccharomyces rouxii Zygosacchromyces rouxii 2435 18 ITS (Internal Transcribed Spacer) ITS (Intergenic Transcribed Spacer) 2446 24 Achyranthes fauriei H. L veill et Vaniot Achyranthes fauriei Leveille et Vaniot / Standard Atomic Weights 2010 2500 7 2 53 58 111 112 8 / 2573 4 2565 4 9 3 30 6 7 / mol/L pH 272 19 100 mL 160 mL / 885 19 929 10 AT ATi 929

7 8 AT ATn 929 4 AT ATi 1056 4 2 mL (1 1) 50 mL 2 mL 50 mL 1107 14 1-(4-Amino-6,7-dimethoxyquinazolin-2-yl) - 4-{[(2RS)-2,3-dihydro-1,4-benzodioxin-2- yl] carbonyl}piperazine monomethanesulfonate 1-(4-Amino-6,7-dimethoxyquinazolin-2-yl) - 4-{[(2RS)-2,3-dihydro-1,4-benzodioxin-2- yl] carbonyl}piperazine monomethansulfonate / 1835 20 1 g 20 mL 1 g 20 10 / 2440 13 1) IARC, IARC monographs on the evaluation of carcinogenic risks to humans, Volume 82.

8 1) IARC, IARC monographs on the evaluation of cartinogenic risks to humans, Volume 82.


Related search queries